Daré Bioscience closes Reg A offering, raises $250K from 50,000 units at $5/unit

Dare Bioscience, Inc.

Issued 50,000 Investor Units at $5.00 each, total gross proceeds $250,000.
Each unit includes one share of Series A Convertible Preferred Stock and two warrants.
Warrants to purchase up to 100,000 shares of common stock.
Offering circular qualified by SEC on April 1, 2026; closings on May 14, 2026.

item 3.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.